Beckman Coulter Life Sciences, a global leader in laboratory automation and innovation, in partnership with Rarity Bioscience AB offers a new approach to oncology research by extending the ...
Beckman Coulter Life Sciences, a global leader in laboratory automation and innovation, continues to lead the way with first-to-market concepts to help laboratories achieve goals faster and with ...
SAN FRANCISCO (MarketWatch) -- Beckman Coulter Inc. will purchase Dako Denmark AS's research flow cytometry instrumentation business based in Fort Collins, Colo., the two companies said Monday.
In this three-part webinar series, we invite you to explore the benefits of a standardized workflow in leukemia and lymphoma analysis. Join this showcase of Beckman Coulter’s new DxFLEX flow cytometer ...
INDIANAPOLIS – (March 19, 2024) – Beckman Coulter Life Sciences, a global leader in laboratory automation and innovation and a subsidiary of Danaher Corporation (NYSE: DHR), continues to lead the way ...
After five decades of use, flow cytometry is entrenched in biomedical science. Besides enabling the quick processing of cells in suspension, flow cytometry provides quantitative results across ...
Beckman Coulter Inc., the Fullerton maker of medical testing instruments and equipment, said Monday that it’s buying a business of Dako Denmark AS. Financial terms weren’t disclosed. Beckman is buying ...
Flow cytometry is a way to look closely at the features of cells or particles. A sample of blood or tissue goes into a machine called a cytometer. In less than a minute, a computer can analyze ...
With flow cytometry, as with many technologies that enjoy continuous use, we can see an evolution of capabilities. Spectral analysis, image capture, and artificial intelligence are just a few of the ...
Extracellular vesicles (EVs) shuttle important biologically active molecules out of cells. Characterizing their size, density, biochemical composition, and cell of origin provide researchers with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results